Pyrrolidine

Pyrrolidine

SCHEMBL712847

C1CCNC1.O=C(O)O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Pyrrolidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Azepane SCHEMBL714889 0.96 ALDH1A1 (0.64)
Piperidine SCHEMBL720107 0.96 ALDH1A1 (0.64)
Piperidine SCHEMBL4577836 0.96 ALDH1A1 (0.64)
Azepane SCHEMBL20740115 0.93 ALDH1A1 (0.60)
Azepane SCHEMBL940042 0.93 ALDH1A1 (0.60)
Azetidine SCHEMBL7551428 0.92
Oxalic Acid SCHEMBL3717458 0.89 ALDH1A1 (0.53)
Bicarbonate SCHEMBL16668464 0.89 CXCR4 (0.64)
Azetidine SCHEMBL27997568 0.88 SLC6A1 (0.43)
Bicarbonate SCHEMBL9715355 0.88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113387957-B Spirocyclic indolone-pyrrolidine carbonate compound and composition, preparation method and application thereof 江苏亚尧生物科技有限公司 2022-08-09 CN claimed
CN-108627647-A A kind of detection of posttranslational modification proteomics and quantitative approach 四川大学 2018-10-09 CN claimed
US-7494630-B2 Method of stripping metals from organic solvents THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) 2009-02-24 US claimed
US-20070225380-A1 Parakeratosis Inhibitor and Skin Preparation for External use SHISEIDO COMPANY LTD. (JP) 2007-09-27 US claimed
US-20070189943-A1 Method of stripping metals from organic solvents ENERGY, UNITED STATES DEPARTMENT OF 2007-08-16 US claimed
EP-1688126-A1 PARAKERATOSIS INHIBITOR AND EXTERNAL COMPOSITION FOR SKIN SHISEIDO COMPANY LIMITED (JP) 2006-08-09 EP claimed
EP-0024382-A1 Piperidine derivatives, their preparation and pharmaceutical compositions containing them af Ekenstam, Bo (SE) 1981-03-04 EP claimed
CN-115927083-B Streptomyces viticola, microbial inoculum containing streptomyces viticola and application of microbial inoculum in low temperature resistance of crops 中化化肥有限公司临沂农业研发中心 2023-06-16 CN disclosed
CN-115927083-A Streptomyces viticola, microbial inoculum containing streptomyces viniferus and application of streptomyces viniferus in low temperature resistance of crops 中化化肥有限公司临沂农业研发中心 2023-04-07 CN disclosed
CN-113387957-B Spirocyclic indolone-pyrrolidine carbonate compound and composition, preparation method and application thereof 江苏亚尧生物科技有限公司 2022-08-09 CN disclosed
CN-113387957-B Spirocyclic indolone-pyrrolidine carbonate compound and composition, preparation method and application thereof 江苏亚尧生物科技有限公司 2022-08-09 CN disclosed
CN-113387957-B Spirocyclic indolone-pyrrolidine carbonate compound and composition, preparation method and application thereof 江苏亚尧生物科技有限公司 2022-08-09 CN disclosed
EP-3806849-A1 SYNTHETIC CYTOTOXIC MOLECULES, DRUGS, METHODS OF THEIR SYNTHESIS AND METHODS OF TREATMENT The Regents of the University of California (US) 2021-04-21 EP disclosed
EP-0437555-B1 PROCESS FOR THE RACEMIC SEPARATION OF 4-ARYL-2-OXO-PYRROLIDINE-3-CARBOXYLIC ACID ESTERS SCHERING AG (DE) 1995-08-30 EP disclosed
EP-0437555-A1 PROCESS FOR THE RACEMIC SEPARATION OF 4-ARYL-2-OXO-PYRROLIDINE-3-CARBOXYLIC ACID ESTERS. SCHERING AG (DE) 1991-07-24 EP disclosed
EP-0433112-A1 Modified gangliosides and the functional derivatives thereof FIDIA S.p.A. (IT) 1991-06-19 EP disclosed
EP-0410883-A2 Di-lysogangliosides derivatives FIDIA S.p.A. (IT) 1991-01-30 EP disclosed
WO-1991000362-A1 PROCESS FOR THE RACEMIC SEPARATION OF 4-ARYL-2-OXO-PYRROLIDINE-3-CARBOXYLIC ACID ESTERS SCHERING AKTIENGESELLSCHAFT (DE) 1991-01-10 WO disclosed
EP-0373039-A2 New lysoganglioside derivatives FIDIA S.p.A. (IT) 1990-06-13 EP disclosed
EP-0024382-A1 Piperidine derivatives, their preparation and pharmaceutical compositions containing them af Ekenstam, Bo (SE) 1981-03-04 EP disclosed